side effects of semaglutide and tirzepatide vs. Semaglutide: What's the Difference? Health Tip of the Week,

But CMS noted that the same medications can be covered by Medicare Part D if theyre prescribed to treat another medical condition: For example, a glucagon-like peptide 1 (GLP-1) receptor agonist that receives FDA approval for chronic weight management alone would not be considered a Part D drug

While no single hormone determines body weight, supporting your body's natural GLP-1 response may make it easier to maintain healthy eating patterns over time

Patients may also experience nausea and vomiting accompanying the pain episodes

David Spiegel MD, Associate Chair of Psychiatry & Behavioral Sciences, Director of the Center on Stress and Health and Director of the Center for Integrative Medicine at Stanford University School of Medicine